日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of PROTACs for targeted degradation of oncogenic TRK fusions

开发用于靶向降解致癌性TRK融合蛋白的PROTAC

Kumar, Saurav; Jiang, Jiewei; Donald-Paladino, Mia S; Chen, Joy; Gutierrez, Andrea; Federation, Alexander J; Szulzewsky, Frank; Holland, Eric C; Ferguson, Fleur M; Nabet, Behnam

Simulated Self-Assessment and Error Correction in Preclinical Prosthodontics: Insights From 3D-Printed Models

模拟自我评估和错误纠正在临床前修复学中的应用:来自3D打印模型的启示

Cuny, Constance; Kumar, Abhishek; Thuries, Alexandre; Fournier, Geromine; Bataille, Coralie; Nabet, Cathy; Galibourg, Antoine

DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancer

DNA损伤反应特征与广泛期小细胞肺癌的一线化疗反应和肿瘤演变途径相关

Morris, Benjamin B; Heeke, Simon; Xi, Yuanxin; Diao, Lixia; Wang, Qi; Rocha, Pedro; Arriola, Edurne; Lee, Myung Chang; Tyson, Darren R; Concannon, Kyle; Ramkumar, Kavya; Stewart, C Allison; Cardnell, Robert J; Wang, Runsheng; Quaranta, Vito; Wang, Jing; Heymach, John V; Nabet, Barzin Y; Shames, David S; Gay, Carl M; Byers, Lauren A

Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer

整合ctDNA分析和放射组学进行局部肺癌动态风险评估

Moding, Everett J; Shahrokh Esfahani, Mohammad; Jin, Cheng; Hui, Angela B; Nabet, Barzin Y; Liu, Yufei; Chabon, Jacob J; Binkley, Michael S; Kurtz, David M; Hamilton, Emily G; Chaudhuri, Aadel A; Liu, Chih Long; Li, Zhe; Bonilla, Rene F; Jiang, Alice L; Lau, Brianna C; Lopez, Pablo; He, Jianzhong; Qiao, Yawei; Xu, Ting; Yao, Luyang; Gandhi, Saumil; Liao, Zhongxing; Das, Millie; Ramchandran, Kavitha J; Padda, Sukhmani K; Neal, Joel W; Wakelee, Heather A; Gensheimer, Michael F; Loo, Billy W Jr; Li, Ruijiang; Lin, Steven H; Alizadeh, Ash A; Diehn, Maximilian

Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations

非小细胞肺癌分子亚型及对免疫疗法联合治疗的敏感性

Lu, Tianshi; Hamidi, Habib; Socinski, Mark A; Reck, Martin; Cappuzzo, Federico; Barlesi, Fabrice; Jotte, Robert M; Müller, Sören; Qamra, Aditi; Amitai, Assaf; Guan, Xiangnan; Fuentes, Eloisa; Koeppen, Hartmut; Giltnane, Jennifer M; Shames, David S; Ballinger, Marcus; He, Meng Xiao; Wang, Yulei; Srivastava, Minu K; Nabet, Barzin Y

Intratumor heterogeneity of EGFR expression mediates targeted therapy resistance and formation of drug tolerant microenvironment

EGFR 表达的肿瘤内异质性介导靶向治疗耐药性和药物耐受微环境的形成

Bassel Alsaed, Linh Lin, Jieun Son, Jiaqi Li, Johannes Smolander, Timothy Lopez, Pinar Ö Eser, Atsuko Ogino, Chiara Ambrogio, Yoonji Eum, Tran Thai, Haiyun Wang, Eva Sutinen, Hilma Mutanen, Hanna Duàn, Nina Bobik, Kristian Borenius, William W Feng, Behnam Nabet, Satu Mustjoki, Sanna Laaksonen, Benja

NOTCH1 reverses immune suppression in small cell lung cancer through reactivation of STING

NOTCH1通过重新激活STING逆转小细胞肺癌中的免疫抑制。

Kim, Yoo Sun; Nabet, Barzin Y; Cortez, Briana N; Sun, Nai-Yun; Sebastian, Robin; Redon, Christophe E; Ray, Anagh; Liu, Liang; Ishola, Afeez A; Loew, Sarah; Dhall, Anjali; Sindiri, Sivasish; Gayevskiy, Velimir; Lee, Min-Jung; Rastogi, Shraddha; Sato, Nahoko; Kedei, Noemi; Andresson, Thorkell; Das, Sudipto; Kumar, Suresh; Bers, Alan E; Zhang, Hongliang; Chiappori, Alberto; Gopal, Priyanka; Abazeed, Mohamed E; Chen, Haobin; Aladjem, Mirit I; Pommier, Yves; Velez, Moises J; Shames, David S; Roper, Nitin

In vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer.

体内功能筛选揭示 KEAP1 缺失是小细胞肺癌化疗耐药性的驱动因素

Brumage Lauren, Best Scott, Hippe Daniel S, Grunblatt Eli, Chanana Pritha, Wu Feinan, Lee Myung Chang, Ying Zhe, Ibrahim Ali, Chung Jae Heun, Vigil Anna, Fatherree Jackson, Beronja Slobodan, Paddison Patrick, Sullivan Lucas, Nabet Barzin, MacPherson David

Clonal hematopoiesis is associated with reduced response to atezolizumab in non-small cell lung cancer

克隆性造血与非小细胞肺癌患者对阿特珠单抗的反应降低有关

Chat, Vylyny; Fletez-Brant, Kipper; Srivastava, Minu; Nabet, Barzin; Mellman, Ira; McCarthy, Mark I; Hammer, Christian

xCell 2.0: robust algorithm for cell type proportion estimation predicts response to immune checkpoint blockade

xCell 2.0:用于细胞类型比例估计的稳健算法,可预测对免疫检查点阻断的反应

Angel, Almog; Naom, Loai; Nabet-Levy, Shir; Aran, Dvir